Perbedaan Brigit Biofarmaka Teknologi Tbk. dan Sat Nusapersada Tbk: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp254 (kapitalisasi pasar 172,82 M, volume 24 jam 592,2 rb), sedangkan Sat Nusapersada Tbk diperdagangkan di Rp246 (kapitalisasi pasar 1,33 T, volume 24 jam 217 rb). Perbedaan utamanya: Sat Nusapersada Tbk jauh lebih besar — sekitar 7,7× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (592,2 rb vs 217 rb). Mana yang lebih baik tergantung tujuan investasimu.
| OBAT | PTSN | |
|---|---|---|
Kapitalisasi Pasar | 172,82 M | 1,33 T |
Volume | 592,2 rb | 217 rb |
Lot | 5,92 rb | 2,17 rb |
Perputaran | 147,05 jt | 53,62 jt |
Harga Rata-rata | 248,31 | 247,12 |
Nilai Transaksi | 147,05 jt | 53,62 jt |
Harga Ekuilibrium Indikatif | 254 | 246 |
Volume Ekuilibrium Indikatif | 10 | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →Sat Nusapersada Tbk (the company) was established on Jun 1, 1990 based on Notaries Deed No. 5 and the deed of establishment was approved by the the Ministry of Justice dated Sept 18, 1991. The Company’s articles of association has been amended several times, most recently by notarial deed No. 14 of Fathiah Helmi, S.H., dated Aug 7, 2007, concerning public offering.
Selengkapnya di halaman PTSN →